Phản Ứng Cytokine Pro-Inflammatory của Tế Bào Biểu Mô A549 với Peptide Kháng Khuẩn Brevinin-2R

Alley MC, Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833 Baroni A, Donnarumma G, Paoletti I, Longanesi-Cattani I, Bifulco K, Tufano MA, Carriero MV (2009) Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 32:267–272 Bowdish DME, Davidson DJ, Speert DP, Hancock REW (2004) The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathway in primary human monocytes. J Immunol 172:3758–3765 Brandenburg LO, Jansen S, Wruck ChJ, Lucius R, Pufe T (2010) Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signaling pathways. Mol Immunol 47:1905–1913 Bulet P, Stocklin R, Menin L (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198:169–184 Eckmann L, Lagnoff MF, Fierer J (1995) Intestinal epithelial cells as watchdogs for the natural immune system. Trends Microbiol 3:118–120 Elssner A, Duncan M, Gavrilin M, Wewers MD (2004) A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing andrelease. J Immunol 172:4987–4994 Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ et al (2008) Brevinin-2R1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med 12:1005–1022 Hancock REW, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8:402–410 Heilborn JD, Nilsson MF, Kratz G, Weber G, Sørensen O, Borregaard N, Stahle-Backdahl M (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120:379–389 Khine AA, Sorbo LD, Vaschetto R et al (2006) Human neutrophil peptides induce interleukin-8 production through the P2Y 6 signaling pathway. Blood 107:2936–2942 Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ (2003) In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides 24:945–953 Lau YE, Bowdish DME, Cossean C, Hancock REW, Davidson DJ (2006) Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am J Respir Cell Mol Biol 34:399–409 Levine SJ (1995) Bronchial epithelial cell–cytokine interactions in airway inflammation. J Investig Med 43:241–249 Mehrnejad F, Naderi-Manesh H, Ranjbar B, Maroufi B, Asoodeh A, Doustdar F (2008) PCR-based gene synthesis, molecular cloning, high level expression, purification, and characterization of novel antimicrobial peptide, brevinin-2R, in Escherichia Coli. Appl Biochem Biotechnol 149:109–118 Peschel A, Sahl HG (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4:529–536 Pfaffl MW (2001) A new mathematical model for relative quantification in real time RT-PCR. Nucleic Acids Res 29:2002–2007 Rosenfeld Y, Papo N, Shai Y, Brady HB (2006) Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 281:1636–1643 Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6:551–557 Shai Y (2002) From innate immunity to de novo designed antimicrobial peptides. Curr Pharm Des 8:715–725 Shamova OV, Sakuta GA, Orlov DS, Zenin VV, Stein GI, Kolodkin NI et al (2007) Effects of antimicrobial peptides of neutrophils on tumor and normal host cells in culture. Cell Tissue Biol 1:524–533 Tjabringa GS, Arabiou J, Ninaber DK, Drijfhout JW, Sørensen OE, Borregaard N et al (2003) The antimicrobial peptide LL-37 activate innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171:6690–6696 Van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Daha MR, Dijkman JH, Hiemstra PS (1997) Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol 272:888–896 Wong ML, Medrano JF (2005) Real-time PCR for mRNA quantitation. Biotechniques 39:1–11 Xu N, Wang YS, Pan WB, Xiao B, Wen YJ, Chen XC et al (2008) Human α-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice. Mol Cancer Ther 7:1588–1597 Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J et al (1999) Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525–528 Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemo attract human peripheral blood neutrophils, monocytes and T cells. J Exp Med 192:1069–1074 Yoshioka M, Fukuishi N, Kubo Y et al (2008) Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol Pharm Bull 31:212–216 Zuyderduyn S, Ninaber DK, Hiemstra PS, Rabe KF (2006) The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells. J Allergy Clin Immunol 117:1328–1335